UnitedHealthcare
Daliresp (roflumilast)
Drugs for the Lungs : Drugs for Asthma/COPD
  • Quantity Limit: limit maximum 1 EA PER 1 day(s)
  • Prior Authorization: COPD (oral):
    Duration: 12 Month(s)
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    COPD associated with chronic bronchitis: Yes
    History of COPD exacerbation: Yes
    Documented Diagnosis: Yes

  • COPD (oral):
    Duration: 12 Month(s)
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    COPD associated with chronic bronchitis: Yes
    History of COPD exacerbation: Yes
    Documented Diagnosis: Yes